ondansetron has been researched along with Anemia, Aplastic in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
Excerpt | Relevance | Reference |
---|---|---|
"Severe aplastic anemia is a life-threatening bone marrow failure disorder." | 2.70 | Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. ( Brodsky, I; Brodsky, RA; Dorr, D; Jones, RJ; Karp, JE; Lee, SM; Seaman, PJ; Sensenbrenner, LL; Smith, BD, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, RA | 1 |
Sensenbrenner, LL | 1 |
Smith, BD | 1 |
Dorr, D | 1 |
Seaman, PJ | 1 |
Lee, SM | 1 |
Karp, JE | 1 |
Brodsky, I | 1 |
Jones, RJ | 1 |
1 trial available for ondansetron and Anemia, Aplastic
Article | Year |
---|---|
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Anti-Bacterial Agents; Antiemetics; Cyclophosphamide; Dru | 2001 |